AR-inhibitor Bicalutamide in Treating Patients With TNBC
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Bicalutamide|OTHER: Physician's Choice
Sponsor: Jinling Hospital, China
Collaborators: Wenzhou Medical University|The First People's Hospital of Lianyungang|Wuxi People's Hospital|Nanning Second People's Hospital|Jiangsu Province Hospital of Traditional Chinese Medicine|The Second Hospital of Nanjing Medical University